Sigyn Therapeutics, Inc. (SIGY)

Sigyn Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 7, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	0	5	6	6	19	44
Market Cap Growth	-98.98%	-16.78%	-4.15%	-66.00%	-57.38%	-
Enterprise Value	3	7	9	8	19	46
Last Close Price	0.03	3.15	4.73	6.80	20.00	51.20
PB Ratio	-0.01	-1.13	-1.78	-3.33	-70.48	441.21
P/TBV Ratio	-	-	-	-	-	566.27
Debt / Equity Ratio	-0.48	-0.49	-0.73	-0.99	-3.53	5.23
Net Debt / Equity Ratio	-0.46	-0.49	-0.72	-0.98	-2.24	4.38
Net Debt / EBITDA Ratio	-1.45	-0.87	-1.01	-0.87	-0.23	-0.48
Net Debt / FCF Ratio	-2.91	-2.50	-1.78	-1.02	-0.33	-0.52
Inventory Turnover	-	-	-	-	1.69	-
Quick Ratio	0.02	0.00	0.00	0.00	0.46	0.14
Current Ratio	0.02	0.01	0.03	0.03	0.54	1.13
Return on Equity (ROE)	-	-	-	-	-	-2563.58%
Return on Assets (ROA)	-417.42%	-588.03%	-468.80%	-257.31%	-226.46%	-
Return on Capital Employed (ROCE)	48.80%	57.20%	74.70%	125.10%	10619.20%	-924.00%
Earnings Yield	-4222.20%	-66.05%	-68.23%	-46.21%	-16.11%	-2.88%
FCF Yield	-	-17.25%	-22.76%	-28.88%	-9.67%	-1.90%
Buyback Yield / Dilution	-28.51%	-21.09%	-17.70%	-2.75%	-395.11%	-1370.26%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 8, 2026

Data Sources Report a data error